TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury
Era Taoufik(Pasteur Hellenic Institute), Lesley Probert(Pasteur Hellenic Institute), Michael Brines(Northwell Health), Edwige Petit(Hospital Arnau de Vilanova), Michael L. Roberts(Regulon (Greece)), Pietro Ghezzi(Brighton and Sussex Medical School), Vivian Tseveleki(Pasteur Hellenic Institute), Manuela Mengozzi(Mario Negri Institute for Pharmacological Research), Samuel Valable(Centre National de la Recherche Scientifique), John Quackenbush(Harvard University), Didier Divoux(Centre National de la Recherche Scientifique), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 103
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k